scispace - formally typeset
G

Gideon Koren

Researcher at Ariel University

Publications -  2007
Citations -  88165

Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.

Papers
More filters
Journal ArticleDOI

Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial

Laura A. Magee, +23 more
- 01 Jun 2016 - 
TL;DR: Pregnancy outcomes, accounting for allocated group, between methyldopa‐treated and labetalol‐treated women in the CHIPS Trial of ‘less tight’ versus ‘tight’ control of pregnancy hypertension are compared.
Journal ArticleDOI

Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta.

Priya Bapat, +6 more
- 01 Jun 2014 - 
TL;DR: Data suggest that, pending further study, dabigatran should not be used for anticoagulation of pregnant women, because the drug may have an adverse effect on fetal blood coagulation.
Journal Article

Toxoplasmosis and pregnancy

Shahnaz A. Chaudhry, +2 more
- 01 Apr 2014 - 
TL;DR: Screening for the detection of T gondii is only performed in Nunavik and other parts of northern Quebec owing to the high prevalence of infection in this region and the high cost associated with testing.
Journal ArticleDOI

Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers

Asnat Walfisch, +4 more
- 08 Aug 2011 - 
TL;DR: The results suggest that 1st trimester exposure to ACE inhibitors and angiotensin receptor blockers is not associated with an elevated risk of major malformations compared with other antihypertensives.
Journal ArticleDOI

Estimation of Fetal Exposure to Drugs of Abuse, Environmental Tobacco Smoke, and Ethanol

Gideon Koren, +3 more
- 01 Feb 2002 - 
TL;DR: The identification of biologic markers of intrauterine exposure to xenobiotics will allow better understanding of etiology and dose-response relationships between cocaine and other recreational drugs.